Eric Lander (Yuri Gripas/Abaca/Sipa USA/Sipa via AP Images)
March 11, 2022 07:29 AM EST
People

Whistle­blow­er com­plaint al­leges more bul­ly­ing, ethics vi­o­la­tions un­der Lan­der's lead­er­ship — re­port

Paul Schloesser

Associate Editor

Just over a month af­ter the famed yet con­tro­ver­sial ge­neti­cist and Broad In­sti­tute found­ing di­rec­tor Er­ic Lan­der re­signed from his role at the White House …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times